Cubist Pharmaceuticals, Incorporated

Merck Sharp + Dohme Corp.

Jian-Qiao Gu

Valdas Jurkauskas

Pradip M Pathare

Jan-Ji Lai

Joseph Terracciano

Nicole Miller Damour

You Seok Hwang

Sudhakar Devidasrao Garad

Kristos Adrian Moshos

Jacob P Sizemore

Carlos Lopez

Akash Jain

This disclosure relates to salt forms of ceftolozane, processes for making these salt forms, and compositions comprising the same. Also disclosed are stabilized compositions of ceftolozane. Provided herein are salt forms of ceftolozane, processes for making these salt forms and compositions comprising the same. The salt forms provided herein include ceftolozane bromide, ceftolozane edisylate, ceftolozane mesylate, ceftolozane chloride, ceftolozane sulfate, ceftolozane maleate, ceftolozane phosphate, and ceftolozane ketoglutarate.

Salt forms of ceftolozane

This disclosure provides compositions containing solid forms of sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate, and methods of manufacturing and using these compositions.

Crystalline form of a &#x3b2;-lactamase inhibitor

This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.

Tazobactam arginine compositions

Growing community of inventors

Lexington, MA, United States of America

Jian-Qiao Gu